What is the next step in managing a patient with a stone at the common hepatic duct that was not removed by Endoscopic Retrograde Cholangiopancreatography (ERCP) and had a stent placed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 11, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Failed ERCP Stone Extraction with Stent Placement

After failed endoscopic stone extraction with stent placement, the next step is to attempt repeat ERCP with advanced stone extraction techniques (mechanical lithotripsy, cholangioscopy-guided lithotripsy) at 2-3 month intervals, with the goal of achieving complete duct clearance in most patients. 1

Immediate Post-Stent Management

The plastic biliary stent you placed provides temporary biliary drainage and allows resolution of acute symptoms (jaundice, cholangitis) in 84-96% of patients. 2, 3 This temporizing measure:

  • Prevents urgent surgical intervention and stabilizes the patient for definitive treatment 2
  • Allows safe transfer to centers with advanced endoscopic expertise if needed 2
  • Reduces stone size in some cases through bile flow around the stent, potentially facilitating later extraction 4

Repeat ERCP Strategy

Schedule repeat ERCP at 2-3 month intervals using a therapeutic duodenoscope with 4.2mm instrument channel for optimal stone extraction capability. 2

Advanced Extraction Techniques to Employ:

  • Mechanical lithotripsy should be the first-line advanced technique for large or impacted stones 1, 2
  • Cholangioscopy-guided electrohydraulic or laser lithotripsy when mechanical lithotripsy fails 5
  • Extracorporeal shock wave lithotripsy (ESWL) as an alternative option 2

Expected Success Rates:

  • 68% of patients achieve clearance with a second ERCP 2
  • 20% require three ERCPs, 6% need four procedures 2
  • Overall success rate of 63% (50 of 79 patients) with repeated attempts 2

Alternative Pathways Based on Clinical Context

For Elderly/High-Risk Surgical Candidates:

Long-term biliary stenting may serve as definitive treatment in patients with:

  • Advanced age (>70-80 years) with multiple comorbidities 3, 4
  • Limited life expectancy 5
  • Prohibitive surgical risk 5

Exchange stents every 5-6 months to prevent occlusion and cholangitis. 3 Plastic stent patency is limited to approximately 3 months, requiring scheduled replacement. 6

For Surgical Candidates:

Refer for percutaneous transhepatic stone removal if repeat endoscopic attempts fail. 1 This approach offers:

  • 95-100% success rates in experienced hands 1
  • Balloon dilation of papilla with stone sweeping into duodenum 1
  • Basket lithotripsy for stones >15mm 1

Surgical bile duct exploration remains an option, though typically reserved after failed percutaneous approaches. 4

Critical Monitoring and Complications

Watch for Stent-Related Complications:

  • Cholangitis occurs in 14% of patients during follow-up, managed with IV antibiotics and early stent replacement 2
  • Stent migration (rare, <2% of cases) 3
  • Stone growth around stent if left in place >2 years without sphincterotomy—this creates a complex requiring en bloc removal 6

Important Pitfall to Avoid:

Never leave a stent in place long-term without sphincterotomy unless the patient is designated for permanent palliative stenting. 6 The lack of sphincterotomy combined with prolonged stent placement can lead to stone encasement of the stent, creating a much more difficult extraction problem. 6

Specific Algorithm for Decision-Making

If patient is <70 years, good surgical candidate:

  • Attempt 2-3 repeat ERCPs with advanced techniques over 6-9 months
  • If unsuccessful → percutaneous transhepatic approach
  • If unsuccessful → surgical exploration

If patient is >75 years with significant comorbidities:

  • Attempt 1-2 repeat ERCPs with advanced techniques
  • If unsuccessful → long-term stenting with 5-6 month exchanges
  • Monitor for cholangitis, maintain low threshold for stent exchange

If patient develops septic shock or refractory cholangitis:

  • Urgent biliary decompression via repeat ERCP or percutaneous drainage 1, 7
  • Broad-spectrum antibiotics within 1 hour 7
  • Consider percutaneous approach if endoscopic access fails 1

Follow-Up Timing

First repeat ERCP should occur at 2-3 months after initial stent placement, allowing time for clinical stabilization and potential stone size reduction. 2 Earlier intervention (within weeks) is only indicated if the patient develops cholangitis despite the stent. 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Stenting for choledocholithiasis: temporizing or therapeutic?

The American journal of gastroenterology, 1996

Research

Endoscopic stenting in the management of biliary stones.

Singapore medical journal, 1996

Research

Endoscopic biliary stenting for irretrievable common bile duct stones: Indications, advantages, disadvantages, and follow-up results.

The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland, 2012

Guideline

Bile Duct and Gallbladder Management Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Removal of a large stone growing around and encasing a plastic biliary stent: respect the ductal axis.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2009

Guideline

Management of Post-ERCP Complications

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

Is cholecystectomy warranted in a patient with a stone at the common hepatic duct who had a stent placed after unsuccessful ERCP (Endoscopic Retrograde Cholangiopancreatography)?
What is the recommended approach for patients undergoing Endoscopic Retrograde Cholangiopancreatography (ERCP)?
In a patient with cholecystitis and a stent (endoscopic stent) placement, should the stent be removed first or should a cholecystectomy be performed first?
What is the differential diagnosis (Ddx) for a patient with new bloody stools and cholangitis, status post (s/p) stent placement and sphincterotomy?
What is the best course of treatment for an 89-year-old female patient with acute cholecystitis, gallbladder hydrops with sludge and calculi, early hepatic cirrhosis, and common bile duct sludge with a common bile duct (CBD) stent in situ, presenting with right upper quadrant (RUQ) pain?
What is the recommended treatment approach for a adult patient with a history of anxiety or depression undergoing tianeptine withdrawal at day 5?
What's going on with my relative, an adult or pediatric patient, who has a severe sinus infection that didn't respond to initial antibiotic treatment and now has completely blocked sinuses above their eyes?
What is the prevention for a patient with a history of allergic reactions, specifically itchiness all over the body, after a blood transfusion, to minimize the risk of a similar or more severe reaction during future transfusions?
What is the appropriate treatment for a female patient with a history of non-compliance to her medication regimen for a pre-existing medical condition, who presents with a category 2 rabies exposure from a cat scratch, stable vital signs, elevated blood pressure, and an abrasion on her right arm?
Does fluoxetine (Prozac) interact with Qelbree (viloxazine) better than sertraline (Zoloft) in patients?
What is the most effective approach to prevent hypersensitivity reactions in a patient undergoing an intravenous (IV) contrast computed tomography (CT) scan?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.